Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Evaluation of intravenous and intraperitoneal pharmacokinetics of dalbavancin in peritoneal dialysis patients.

Van Matre ET, Teitelbaum I, Kiser TH.

Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02089-19. doi: 10.1128/AAC.02089-19. [Epub ahead of print]

PMID:
32122898
2.

International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis.

Brown EA, Blake PG, Boudville N, Davies S, de Arteaga J, Dong J, Finkelstein F, Foo M, Hurst H, Johnson DW, Johnson M, Liew A, Moraes T, Perl J, Shroff R, Teitelbaum I, Wang AY, Warady B.

Perit Dial Int. 2020 Jan 21:896860819895364. doi: 10.1177/0896860819895364. [Epub ahead of print] No abstract available.

PMID:
32063219
3.

Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: A systematic review.

Sahlawi MA, Wilson G, Stallard B, Manera KE, Tong A, Pisoni RL, Fuller DS, Cho Y, Johnson DW, Piraino B, Schreiber MJ, Boudville NC, Teitelbaum I, Perl J.

Perit Dial Int. 2020 Mar;40(2):132-140. doi: 10.1177/0896860819893810. Epub 2020 Jan 17.

PMID:
32063197
4.

Prescribing high-quality peritoneal dialysis: The role of preserving residual kidney function.

Chen CH, Perl J, Teitelbaum I.

Perit Dial Int. 2020 Jan 17:896860819893821. doi: 10.1177/0896860819893821. [Epub ahead of print]

PMID:
32063188
5.

"Can I go to Glasgow?" Learnings from patient involvement at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD).

Gutman T, Manera KE, Baumgart A, Johnson DW, Wilkie M, Boudville N, Craig JC, Dong J, Jesudason S, Mehrotra R, Neu A, Shen JI, Van Biesen W, Blake PG, Brunier G, Cho Y, Jefferson N, Lenga I, Mann N, Mendelson AA, Perl J, Sanabria RM, Scholes-Roberston N, Schwartz D, Teitelbaum I, Tong A.

Perit Dial Int. 2020 Jan;40(1):12-25. doi: 10.1177/0896860819880101.

PMID:
32063150
6.

Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).

Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y, Nessim SJ, Piraino BM, Pisoni RL, Robinson BM, Schaubel DE, Schreiber MJ, Teitelbaum I, Woodrow G, Zhao J, Johnson DW.

Am J Kidney Dis. 2020 Jan 10. pii: S0272-6386(19)31105-9. doi: 10.1053/j.ajkd.2019.09.016. [Epub ahead of print]

7.

Eradication of Repeated Episodes of Coagulase-Negative Staphylococcus Peritonitis: a Multipronged Approach.

Haivas CD, Teitelbaum I.

Perit Dial Int. 2019 Nov-Dec;39(6):568-570. doi: 10.3747/pdi.2019.00247.

PMID:
31690701
8.

Attitudes toward Peritoneal Dialysis among Peritoneal Dialysis and Hemodialysis Medical Directors: Are We Preaching to the Right Choir?

Shen JI, Schreiber MJ, Zhao J, Robinson BM, Pisoni RL, Mehrotra R, Oliver MJ, Tomo T, Tungsanga K, Teitelbaum I, Ghaffari A, Lambie M, Perl J.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1067-1070. doi: 10.2215/CJN.01320119. No abstract available.

PMID:
31278114
9.

Prevention of Peritoneal Dialysis Drop-Out.

Ambruso SL, Teitelbaum I.

Adv Perit Dial. 2018 Nov;34(2018):19-23. Review.

PMID:
30480532
10.

Crafting the Prescription for Patients Starting Peritoneal Dialysis.

Teitelbaum I.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):483-485. doi: 10.2215/CJN.10770917. Epub 2018 Jan 30. No abstract available.

11.

Early peritoneal dialysis reduces lung inflammation in mice with ischemic acute kidney injury.

Altmann C, Ahuja N, Kiekhaefer CM, Andres Hernando A, Okamura K, Bhargava R, Duplantis J, Kirkbride-Romeo LA, Huckles J, Fox BM, Kahn K, Soranno D, Gil HW, Teitelbaum I, Faubel S.

Kidney Int. 2017 Aug;92(2):365-376. doi: 10.1016/j.kint.2017.01.020. Epub 2017 Mar 16.

12.

The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics.

Perl J, Dember LM, Bargman JM, Browne T, Charytan DM, Flythe JE, Hickson LJ, Hung AM, Jadoul M, Lee TC, Meyer KB, Moradi H, Shafi T, Teitelbaum I, Wong LP, Chan CT; American Society of Nephrology Dialysis Advisory Group.

Clin J Am Soc Nephrol. 2017 May 8;12(5):839-847. doi: 10.2215/CJN.08460816. Epub 2017 Mar 17. Review.

13.

Peritoneal Membrane Preservation.

Bajo MA, Del Peso G, Teitelbaum I.

Semin Nephrol. 2017 Jan;37(1):77-92. doi: 10.1016/j.semnephrol.2016.10.009. Review.

PMID:
28153197
14.

ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW.

Perit Dial Int. 2016 Sep 10;36(5):481-508. doi: 10.3747/pdi.2016.00078. Epub 2016 Jun 9. Review. No abstract available. Erratum in: Perit Dial Int. 2018 Jul-Aug;38(4):313.

15.

Ultrafiltration failure in peritoneal dialysis: a pathophysiologic approach.

Teitelbaum I.

Blood Purif. 2015;39(1-3):70-3. doi: 10.1159/000368972. Epub 2015 Jan 20. Review.

16.

Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.

Cozzolino M, Funk F, Rakov V, Phan O, Teitelbaum I.

Curr Drug Metab. 2014;15(10):953-65. Review.

17.

Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.

Kiser TH, Fish DN, Aquilante CL, Rower JE, Wempe MF, MacLaren R, Teitelbaum I.

Crit Care. 2015 Feb 3;19:32. doi: 10.1186/s13054-015-0753-8.

18.

Peritoneal dialysis: update on patient survival.

Teixeira JP, Combs SA, Teitelbaum I.

Clin Nephrol. 2015 Jan;83(1):1-10. doi: 10.5414/CN108382. Review.

19.

Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review.

Bieber SD, Burkart J, Golper TA, Teitelbaum I, Mehrotra R.

Am J Kidney Dis. 2014 Jun;63(6):1027-37. doi: 10.1053/j.ajkd.2013.11.025. Epub 2014 Jan 11. Review.

20.

Strategies for the preservation of residual renal function in pediatric dialysis patients.

Cadnapaphornchai MA, Teitelbaum I.

Pediatr Nephrol. 2014 May;29(5):825-36; quiz 832. doi: 10.1007/s00467-013-2554-0. Epub 2013 Jul 19. Review.

PMID:
23868107
21.

Basically, dialysis is not good enough.

Furgeson SB, Teitelbaum I.

Clin J Am Soc Nephrol. 2013 Feb;8(2):177-8. doi: 10.2215/CJN.12781212. Epub 2013 Jan 10. No abstract available.

22.

Care of the patient after renal allograft failure: managing the present and planning for the future.

Fuquay R, Teitelbaum I.

Am J Nephrol. 2012;36(4):348-54. doi: 10.1159/000342626. Epub 2012 Sep 26. Review.

23.

Transplant outcomes and dialysis modality.

Fuquay R, Teitelbaum I.

Contrib Nephrol. 2012;178:251-257. doi: 10.1159/000337887. Epub 2012 May 25. Review.

PMID:
22652746
24.

Time between peritoneal dialysis catheter insertion and use.

Elhassan E, Teitelbaum I.

Contrib Nephrol. 2012;178:228-231. doi: 10.1159/000337883. Epub 2012 May 25.

PMID:
22652742
25.

Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysis.

Warnock DG, Hebbar S, Bargman J, Burkart J, Davies S, Finkelstein FO, Mehrotra R, Ronco C, Teitelbaum I, Urakpo K, Chertow GM.

Contrib Nephrol. 2012;178:157-163. doi: 10.1159/000337837. Epub 2012 May 25. Review.

PMID:
22652731
26.

Alternative dialysis strategies with icodextrin.

Panzer SE, Teitelbaum I.

Contrib Nephrol. 2012;178:11-15. doi: 10.1159/000337790. Epub 2012 May 25. Review.

PMID:
22652709
27.

The response to methylene blue in patients with severe hypotension during liver transplantation.

Cheng SS, Berman GW, Merritt GR, Hendrickse A, Fiegel MJ, Teitelbaum I, Campsen J, Wachs M, Zimmerman M, Mandell MS.

J Clin Anesth. 2012 Jun;24(4):324-8. doi: 10.1016/j.jclinane.2011.10.010.

PMID:
22608589
28.

Peritoneal dialysis after cardiothoracic surgery: do it!

Teitelbaum I.

Perit Dial Int. 2012 Mar-Apr;32(2):131-3. doi: 10.3747/pdi.2011.00199. No abstract available.

29.

Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients.

Duong U, Kalantar-Zadeh K, Molnar MZ, Zaritsky JJ, Teitelbaum I, Kovesdy CP, Mehrotra R.

Am J Nephrol. 2012;35(2):198-208. doi: 10.1159/000335685. Epub 2012 Jan 26.

30.

Preservation of residual renal function in dialysis patients.

Thomas J, Teitelbaum I.

Adv Perit Dial. 2011;27:112-7. Review.

PMID:
22073841
31.

Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis.

Golper TA, Saxena AB, Piraino B, Teitelbaum I, Burkart J, Finkelstein FO, Abu-Alfa A.

Am J Kidney Dis. 2011 Dec;58(6):879-85. doi: 10.1053/j.ajkd.2011.06.028. Epub 2011 Sep 8.

PMID:
21903316
32.

Prolonged duration of peritoneal dialysis catheter embedment does not lower the catheter success rate.

Elhassan E, McNair B, Quinn M, Teitelbaum I.

Perit Dial Int. 2011 Sep-Oct;31(5):558-64. doi: 10.3747/pdi.2010.00160. Epub 2011 May 31.

PMID:
21632444
33.

Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances.

Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, Miller BW, Teitelbaum I, Williams AW, Finkelstein FO; FREEDOM Study Group.

Clin J Am Soc Nephrol. 2011 May;6(5):1049-56. doi: 10.2215/CJN.10451110. Epub 2011 Mar 17.

34.

Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.

Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I.

Pharmacotherapy. 2010 Nov;30(11):1117-26. doi: 10.1592/phco.30.11.1117.

PMID:
20973685
35.

Strategies for improving long-term survival in peritoneal dialysis patients.

Kendrick J, Teitelbaum I.

Clin J Am Soc Nephrol. 2010 Jun;5(6):1123-31. doi: 10.2215/CJN.04300709. Epub 2010 Apr 29. Review.

36.

Preventing burnout in peritoneal dialysis patients.

Moore R, Teitelbaum I.

Adv Perit Dial. 2009;25:92-5.

PMID:
19886326
37.

New treatment options and protocols for peritoneal dialysis-related peritonitis.

Furgeson SB, Teitelbaum I.

Contrib Nephrol. 2009;163:169-176. doi: 10.1159/000223796. Epub 2009 Jun 3.

PMID:
19494611
38.

Adequacy of peritoneal dialysis: beyond small solute clearance.

Goldberg R, Yalavarthy R, Teitelbaum I.

Contrib Nephrol. 2009;163:147-154. doi: 10.1159/000223793. Epub 2009 Jun 3. Review.

PMID:
19494608
39.

Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients.

Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R.

Clin J Am Soc Nephrol. 2009 Jun;4(6):1089-96. doi: 10.2215/CJN.00290109. Epub 2009 May 7.

40.

Peritoneal dialysis adequacy: not just small-solute clearance.

Yalavarthy R, Teitelbaum I.

Adv Perit Dial. 2008;24:99-103. Review.

PMID:
18986011
41.

Acute renal failure and chronic kidney disease following liver transplantation.

Yalavarthy R, Edelstein CL, Teitelbaum I.

Hemodial Int. 2007 Oct;11 Suppl 3:S7-12. Review.

PMID:
17897111
42.

The International Pediatric Peritonitis Registry: starting to walk.

Teitelbaum I.

Kidney Int. 2007 Dec;72(11):1305-7.

43.

Sterile peritonitis with monocytic predominance secondary to acute rejection of a previously failed renal allograft.

Yalavarthy R, Teitelbaum I.

Perit Dial Int. 2007 Jul-Aug;27(4):466-7. No abstract available.

PMID:
17602159
44.

Contribution of acute kidney injury toward morbidity and mortality in burns: a contemporary analysis.

Coca SG, Bauling P, Schifftner T, Howard CS, Teitelbaum I, Parikh CR.

Am J Kidney Dis. 2007 Apr;49(4):517-23.

PMID:
17386319
45.

A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.

Weiss AS, Lucia MS, Teitelbaum I.

Nat Clin Pract Nephrol. 2007 Feb;3(2):111-5.

PMID:
17251999
46.

The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.

Teitelbaum I, Chilvers M, Reiz RJ.

Can J Cardiol. 2004 Oct;20 Suppl C:11C-16C.

PMID:
16807618
47.

Peritoneal dialysis is appropriate for elderly patients.

Teitelbaum I.

Contrib Nephrol. 2006;150:240-246. doi: 10.1159/000093600. Review.

PMID:
16721016
48.

Cloudy peritoneal dialysate: it's not always infection.

Teitelbaum I.

Contrib Nephrol. 2006;150:187-194. doi: 10.1159/000093594. Review.

PMID:
16721010
49.

Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function.

Astor TL, Weill D, Cool C, Teitelbaum I, Schwarz MI, Zamora MR.

J Heart Lung Transplant. 2005 Dec;24(12):2091-7. Epub 2005 Sep 21.

PMID:
16364855
50.

Patient characteristics associated with defects of the peritoneal cavity boundary.

Van Dijk CM, Ledesma SG, Teitelbaum I.

Perit Dial Int. 2005 Jul-Aug;25(4):367-73.

PMID:
16022094

Supplemental Content

Loading ...
Support Center